We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$460M
AUM Growth
-$19.1M
Cap. Flow
-$3.4M
Cap. Flow %
-0.74%
Top 10 Hldgs %
71.83%
Holding
94
New
1
Increased
7
Reduced
8
Closed
8

Top Buys

1
MIST icon
Milestone Pharmaceuticals
MIST
+$4.28M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.7M
3
CUE icon
Cue Biopharma
CUE
+$934K
4
OPTN
OptiNose
OPTN
+$666K
5
GPGI
GPGI Inc
GPGI
+$281K

Top Sells

1
TCDA
Tricida, Inc. Common Stock
TCDA
+$5.24M
2
LIN icon
Linde
LIN
+$3.76M
3
HCAR
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
+$1.49M
4
CELC icon
Celcuity
CELC
+$502K
5
BKTI icon
BK Technologies
BKTI
+$481K

Sector Composition

1 Consumer Discretionary 19.02%
2 Healthcare 16.99%
3 Industrials 15.02%
4 Financials 13.87%
5 Materials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLGCW
76
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$5.61K ﹤0.01%
14,020
– –
WBD icon
77
Warner Bros
WBD
$68.4B
$3.78K ﹤0.01%
399
– –
ASTR
78
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$3.37K ﹤0.01%
518
– –
WGS icon
79
GeneDx Holdings
WGS
$1.8B
$2.64K ﹤0.01%
303
-3,030
-91% -$66.8K
BRIVW
80
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$2.25K ﹤0.01%
75,000
– –
AVNW icon
81
Aviat Networks
AVNW
$282M
$2.06K ﹤0.01%
66
– –
ADEA icon
82
Adeia
ADEA
$2.73B
$853 ﹤0.01%
90
-250
-74% -$2.54K
PACXW
83
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$354 ﹤0.01%
708,333
– –
XPER icon
84
Xperi
XPER
$355M
$293 ﹤0.01%
+34
New +$389
QTEKW
85
DELISTED
QualTek Services Inc. Warrant
QTEKW
$154 ﹤0.01%
3,750
– –
CZOO.WS
86
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
$20 ﹤0.01%
2,500
– –
BKTI icon
87
BK Technologies
BKTI
$293M
– –
-39,880
Closed -$481K
CELC icon
88
Celcuity
CELC
$4.31B
– –
-50,000
Closed -$502K
FLNA
89
Filana Therapeutics
FLNA
$51.2M
– –
-5,000
Closed -$209K
SLGC
90
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-70,100
Closed -$203K
TCDA
91
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-500,000
Closed -$5.24M
HCARW
92
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
– –
-75,000
Closed -$2K
HCAR
93
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
– –
-150,000
Closed -$1.49M
SHLX
94
DELISTED
Shell Midstream Partners, L.P.
SHLX
– –
-1,000
Closed -$16K
1 2 3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q4 2022 Portfolio in Review

As of Q4 2022, Bleichroeder LP held 94 positions worth $460M, down 4% from $479M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bleichroeder LP's Q4 2022 filing shows 1 new, 7 increased, 8 reduced and 8 closed positions. Its largest new stake was Xperi: 34 shares worth $293. The largest sale was Tricida, Inc. Common Stock, an estimated $5.24M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Bleichroeder LP's largest Q4 2022 buy was Xperi: 34 shares worth $293.
  • Bleichroeder LP added most to Milestone Pharmaceuticals in Q4 2022, an estimated $4.28M increase.
  • Bleichroeder LP's biggest Q4 2022 reduction was Linde, cutting an estimated $3.76M.
  • Bleichroeder LP fully exited Tricida, Inc. Common Stock in Q4 2022, selling an estimated $5.24M.
  • Bleichroeder LP's ten largest holdings make up 72% of its $460M portfolio in Q4 2022.
  • Bleichroeder LP opened 1 new position and closed 8 in Q4 2022.
  • Bleichroeder LP's portfolio value fell 4% quarter-over-quarter to $460M.

Based on Bleichroeder LP's 13F filing for Q4 2022, filed 14 Feb 2023.